Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Syrosingopine

    • Product Name Syrosingopine
    • Alias Dehydroemetine
    • Einecs 209-718-2
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    446850

    Cas Number 84-35-9
    Molecular Formula C35H42N2O11
    Molecular Weight 666.71 g/mol
    Iupac Name methyl (2S,3R,12bR)-3-ethyl-1,2,3,4,6,7,12,12b-octahydro-2-[(1S)-1-hydroxyethyl]-6,12b-dimethoxy-1,11-dimethylindolo[2,3-a]quinolizin-1-yl-3,4,5-trimethoxybenzoate
    Synonyms Syrosingopine, Syrosingopin
    Appearance White to off-white powder
    Melting Point 163-165°C
    Solubility Soluble in methanol, ethanol, and chloroform; slightly soluble in water
    Storage Temperature 2-8°C (Refrigerated)
    Pharmacological Class Antihypertensive agent

    As an accredited Syrosingopine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Syrosingopine is supplied in a 1-gram amber glass vial with a screw cap, labeled with product details, handling, and hazard warnings.
    Shipping Syrosingopine is shipped in accordance with chemical safety regulations, typically in tightly sealed, labeled containers to protect against moisture and contamination. It is packed with appropriate cushioning and secondary containment, and accompanied by relevant Safety Data Sheets (SDS). Shipping is restricted to authorized recipients and may require temperature control, depending on local regulations.
    Storage Syrosingopine should be stored in a tightly closed container, protected from light and moisture. Keep it at a temperature between 2-8°C (refrigerated conditions). Store in a well-ventilated, dry area away from incompatible substances such as strong oxidizers. Always handle under appropriate safety conditions and follow institutional or manufacturer guidelines for storage and disposal.
    Application of Syrosingopine

    Applications of Syrosingopine in Industrial Manufacturing

    Syrosingopine developed at our facility is manufactured under controlled and validated processes, supporting high purity requirements across active pharmaceutical, research chemical, and fine chemical sectors. Below we detail real, regulated industrial channels, with application specifics for Syrosingopine, rooted in compliance, process utility, and production outcomes.

    1. Active Pharmaceutical Ingredient (API) Synthesis for Antihypertensive Drugs

    Pharmaceutical companies utilize Syrosingopine as an API or intermediate in the formulation and production of prescription medications targeting hypertension management. Our supply is customized for integration into solid oral dosage forms, typically via wet granulation processes, ensuring close monitoring of impurity profiles and particle size to match downstream tablet pressing and capsule filling operations.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • Ph. Eur. (European Pharmacopoeia) Monographs where applicable
    • USP (United States Pharmacopeia) reference for process and impurity limits
    • China GMP 2020 for pharmaceutical raw materials

    Typical usage ratio

    • Employed as major constituent in tablet/capsule dosage at 5–30% w/w, depending on finished dose strength specifications.

    Downstream process integration

    • Crystalline form incorporated during blending and direct compression or wet granulation, before tableting or encapsulation steps.

    Final product types

    • Antihypertensive tablets
    • Antihypertensive capsules
    • Oral suspensions (in some geographic markets)
    • Finished prescription pharmaceuticals for cardiovascular indications

    2. Reference Standard in Pharmaceutical Quality Control

    Leading pharmaceutical laboratories and bioanalytical CROs source Syrosingopine as a certified reference standard for validating final dosage forms containing reserpine or related alkaloids. Controlled lot-to-lot reproducibility in our supply chain allows for reliable quantification, stability studies, and calibration of HPLC and LC-MS equipment, directly supporting regulatory submission workflows.

    Industry compliance standards

    • European Pharmacopoeia general chapters on reference standards
    • USP Chapter <621> Chromatography quality guidelines
    • WHO Good Laboratory Practice (GLP) for pharmaceutical testing
    • FDA 21 CFR Part 211 Subpart I—Laboratory Controls applicable to API testing

    Typical usage ratio

    • Utilized at microgram-to-milligram quantities for assay, calibration, and system suitability tests—precise amounts defined by validated lab protocols per run.

    Downstream process integration

    • Added at the analytical method setup stage, acting as calibration or validation spike during HPLC, LC-MS, or GC analyses of pharmaceutical batches.

    Final product types

    • Analytical reference solutions
    • Calibration mixtures for laboratory equipment
    • Quality control test kits
    • Pharmaceutical batch certificates and dossiers

    3. Synthetic Intermediate for Linked Rauwolfia Alkaloids

    Industrial research groups involved in total synthesis or semi-synthetic modification of complex indole alkaloids procure Syrosingopine as a key intermediate. Its structure serves as a privileged core, undergoing targeted functional group manipulations such as N-alkylation and selective oxidations before moving towards further functionalized alkaloids. All batches are accompanied by full structure elucidation and residual solvent analysis to support batch scale-up and reproducibility in pilot reactors.

    Industry compliance standards

    • ISO 9001:2015 for chemical manufacturing and R&D process traceability
    • IUPAC best practice guidelines for structure validation
    • REACH registration for safe handling in chemical synthesis
    • OECD Guidelines for Testing of Chemicals applied during new molecule development

    Typical usage ratio

    • Integrated in batch reactors at a 1:1 or slightly stoichiometric excess relative to coupling or derivatizing reagents. Adjusted based on desired downstream alkaloid yield and conversion efficiency.

    Downstream process integration

    • Fed directly into multi-step synthesis pathways, typically at the initial stage of core structure modification or first functionalization reaction in batch or semi-continuous reactors.

    Final product types

    • Semi-synthetic indole alkaloids
    • Pharmaceutical intermediates for further development
    • API precursors for investigational new drugs
    • Research-grade complex organic compounds

    4. Bioactive Probe in Oncology Preclinical Research

    Preclinical R&D divisions at universities and private innovation centers apply Syrosingopine as a selective probe molecule in metabolic inhibition studies and drug mechanism evaluation. Provided with low endotoxin and trace impurity documentation from our QA, Syrosingopine enables metabolic pathway tracing and gene expression assays in vitro and in vivo, with aliquots dispensed according to validated cell culture protocols or rodent dosing schedules.

    Industry compliance standards

    • GLP (Good Laboratory Practice) for preclinical research
    • OECD Principles of Good Laboratory Practice
    • Institutional Animal Care and Use Committee (IACUC) animal testing approvals
    • ISO/IEC 17025 quality standards related to chemical reference supply

    Typical usage ratio

    • Dosed at 0.1–25 μM in cell culture models; mg/kg scale for in vivo studies. Exact concentration varies based on pathway focus, cell line sensitivity, and organism type.

    Downstream process integration

    • Diluted in compatible vehicles for immediate addition to cell cultures or preparation in dosing solutions for animal models, during metabolic, cytotoxicity, or drug synergy experiments.

    Final product types

    • Preclinical assay readouts and experimental datasets
    • Investigational protocol packages for journal submission
    • Compound libraries for pathway screening
    • Supporting data for new drug discovery programs

    5. Raw Material for Pharmacological Toxicity Testing Services

    Contract research organizations (CROs) engage Syrosingopine in toxicity screening workflows, supporting regulatory safety dossiers for new molecular entities. Products are supplied with complete impurity profiles, elemental analysis, and batch traceability documentation, fulfilling third-party auditor requirements. Delivery formats are tailored to the testing schedule—bulk powder or pre-measured ampoules.

    Industry compliance standards

    • OECD Test Guidelines for acute and chronic toxicity studies
    • ICH M3(R2) Nonclinical Safety Studies requirements
    • GLP-certified laboratory protocols
    • FDA/EMA IND-enabling toxicity study frameworks

    Typical usage ratio

    • Standard single-dose or repeated-dose levels designed according to compound solubility and toxicity panel specifications, usually ranging from 0.5–250 mg/kg in animal models.

    Downstream process integration

    • Dispensed directly into in vivo dosing solutions or in vitro assay media during defined toxicity study timelines, conforming to protocol amendments and dosing group stratifications.

    Final product types

    • GLP-compliant toxicology study reports
    • Data files for IND/IMPD submissions
    • Summary tables for regulatory response packages
    • Validated safety assessments for biopharmaceutical sponsors
    Free Quote

    Competitive Syrosingopine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Syrosingopine: A Closer Look from the Manufacturer’s Bench

    Trust Built on the Chemistry of Reliable Production

    Anyone who spends their days in a chemical manufacturing plant quickly learns the difference between a product you can rely on and one that brings more trouble than value. Years of hands-on experience have taught us that a successful synthesis doesn’t just hinge on temperature and pH meters. It’s built on process knowledge, consistent raw material quality, and a team that cares about every batch. We spend a lot of time listening to our partners in research and production, so we know why selecting the right syrosingopine supplier matters: you need purity, transparency, repeatability — and a manufacturer who understands every layer of the pipeline.

    Understanding Syrosingopine’s Chemical Backbone

    Syrosingopine stands out in any chemical line-up. This compound, a vasicine derivative, draws interest from professionals interested in alkaloids and their diverse applications. On our production floor, we see an increasing demand due to its documented ability to inhibit glycolysis and potential relevance as a supporting tool in metabolic research. Quality control chemists sit down each week to run detailed analyses — not just for compliance but to understand every nuance in impurity profiles and polymorphic stability. Our process uses well-proven methods, not shortcuts, because customers count on a crystalline product that behaves predictably every time.

    Specifications That Reflect Real-World Expectations

    We manufacture syrosingopine to meet the high standards expected by pharmaceutical labs, academic research groups, and industrial pilot lines. A typical batch watches over its purity, commonly at 98% or greater by HPLC. Moisture content, heavy metal contamination, and specific optical rotations all earn careful scrutiny. We don’t just work down a checklist. Every parameter speaks to long-term experience about what causes headaches in synthesis, storage, and formulation. If our in-process technicians see odd results, the batch doesn’t leave.

    Direct from the Source: What Sets Manufacturing Apart

    Not every source handles the entire journey from raw material to finished syrosingopine. Our plant receives raw botanical sources through validated and transparent supply chains. Extracted intermediates undergo full chemical synthesis, and each transformation passes through rigorous analytics. Having direct control means we can fine-tune reaction conditions, inspect intermediates, and intervene at the earliest sign of trouble. Some providers offer only repackaging or contract synthesis elsewhere, but we keep everything integrated. This approach saves downstream labs time on troubleshooting — purity alone tells only half the story; ease of handling, solubility, and polymorphic consistency influence how a product performs in real research conditions.

    Why Purity Alone Doesn't Tell the Whole Story

    A lab technician once remarked that two bottles of syrosingopine with identical labels behaved entirely differently in extraction trials. Purity, it turned out, wasn’t the problem. Batch-to-batch variances in solvents, particle size, and trace by-products changed the chemistry enough to ruin repeatability. Our experience emphasizes rigorous in-process controls, so we can guarantee not just the numbers, but a product that “acts right” from shipment to shelf. Whether your project involves metabolic profiling, chemical probe development, or preparing formulations for animal models, confidence in your material makes the rest of your work possible.

    How Industry Feedback Shapes Manufacturing

    Feedback from end-users matters, and our team actively seeks it out. Synthetic chemists, process engineers, and bench researchers have pointed out how seemingly minor changes in syrosingopine batches create ripple effects across workflows. From dissolution rates and filterability to sensitivity to ambient humidity, small variances cascade into bigger headaches. As a result, we revisit our own SOPs after every customer report. These exchanges shaped our quality policy and batch documentation — clients want more than a data sheet stapled to a drum; they want traceability, context, and technical dialogue.

    Comparing Syrosingopine to Other Alkaloids

    A question that floats through technical calls goes like this: how does our syrosingopine differ from other plant-derived alkaloids used in research? Vasicine and reserpine often make the conversation, both for their history and roles in scientific work. Syrosingopine's structure nudges its activity toward unique cellular mechanisms, notably as a dual inhibitor in energy metabolism studies, which the others do not offer. Chemically, its slight difference in functional groups translates into altered reactivity with common solvents and reagents. Our production team pays close attention to these differences. For example, storing and transporting syrosingopine takes stricter humidity control compared to reserpine, and synthesis quenching steps require alternate protocols to avoid partially oxidized by-products.

    Practical Impact: Storage and Handling Insights

    Day-to-day use of syrosingopine highlights practical considerations that often get lost in catalog descriptions. Our warehouse teams learned early that even minor shifts in storage temperature encourage caking or off-coloring when moisture controls get sloppy. We implemented vacuum-sealed packaging because a year’s supply can easily spoil in a shared research fridge. End users count on a white to off-white crystalline solid that stores well and weighs out easily. We chose our current mill and drying equipment after a long trial period to keep batch consistency tight; this minimized frustration down the chain, especially for those preparing sensitive biological assays.

    Supporting Advanced Research Applications

    Syrosingopine's renewed popularity traces back to metabolic research, especially recent projects exploring glycolysis and mitochondrial modulation. Manufacturing offers a unique vantage point: we see which synthetic routes and purification methods work best not only in theory, but in real labs with real pressures. Recent university collaborations pointed out subtle issues with cross-contamination when batches share glassware with similar indole alkaloids. In response, we committed dedicated synthesis lines and in-house analytics for every order above certain thresholds. By investing in compartmentalized facilities, we reduced cross-compound interference and responded quicker to custom requests.

    Adaptation and Customization in the Manufacturing Workflow

    Over time, some partners requested custom grades and blends for unique solvent systems or specific bioassays. Not every standard can fit every research need. Learning from these custom orders, our team adjusted reaction conditions, washing protocols, and drying parameters. The goal is never to force-fit a product, but to understand precisely what the next researcher is looking for. During scale-up projects, pilot partners often requested matched batches — split lots from a single production run — for parallel biological evaluation. This feedback shapes how we schedule equipment and design our batch records.

    Regulatory Clarity and Traceability

    Pharmaceutical and academic clients both ask detailed questions about traceability. We provide full batch histories, including starting material lots, analytic results, and chain-of-custody records. Regulatory compliance, especially in global supply, shapes our workflow. We commit to documented supply chain audits and keep production logs accessible for years beyond standard retention requirements. No shortcuts or “approximations” — every gram is accounted for because even a minor documentation gap can bring progress to a halt for our partners.

    Shipping Syrosingopine: Learning From the Real-World Logistics

    Ordinary shipping mistakes cost time and money, but for a specialized alkaloid like syrosingopine, one misstep can also ruin a project. Logistics teams report back from the field with important lessons: don't trust third-party packaging, stick to dedicated shippers, and track temperature closely, especially on longer routes. Each time a batch got delayed in customs, we analyzed what happened and shared what we learned with the client. Improved labeling, double-barrier vacuum packs, and staff trained on hazardous shipping made the ride smoother. Every improvement grew out of this real-world back and forth — not just following guidelines, but building on hard-won experience.

    Problem Solving: Overcoming Unexpected Hurdles

    During the many years we've spent scaling up alkaloid production, not every batch runs to the textbook plan. A change in the botanical source caused small but crucial changes in extraction efficiency; shifts in the market required alternate solvents, each with its own quirks. Our chemists meet frequently to troubleshoot as a team, sometimes consulting partner labs to get a different perspective. The collective knowledge across the plant means we don’t stick to one dogma — we test, adapt, and update every process as new challenges come up. As a result, our syrosingopine now meets higher standards and arrives in a more robust condition than in previous years.

    What It Really Means to Be a Manufacturer

    From a manufacturer’s chair, it’s easy to spot the difference between repackaged chemistry and true hands-on production. Our advantage comes from touching every step — weighing, mixing, filtering, packaging — and knowing the faces behind the analytics. We see how the industry bends and shifts; new research insights, changing regulations, and customer-driven tweaks all change the roadmap. Each batch reflects not only strict procedures but also a commitment to real communication with the people who rely on our work. Labs worldwide look beyond the price tag. They want confidence in their materials, in the transparency of their supplier, and in the expertise built through years of continuous improvement.

    Looking Ahead: Innovation Rooted in Experience

    Long-lasting relationships with research groups, pharmaceutical developers, and even peer manufacturers shape how we view innovation. We don't chase trends, but we watch them closely and prepare to adapt. Syrosingopine’s renewed attention by the academic community keeps our teams busy solving new analytical puzzles and offering variant grades for tighter tolerances. In recent years, interest in bioactive alkaloids from sustainable sources drove us to review our procurement and extraction pipelines, ensuring everything remains both efficient and responsible. We engage with technical partners early in new projects, looking for challenges that push our capabilities. This drives us to not only improve existing methods, but to look for those moments when a change in the process can directly benefit a collaborator’s outcome.

    The Human Side of Chemical Manufacturing

    Any reliable product, especially in the world of specialty alkaloids, represents more than just a series of steps on a technical sheet. At our plant, the daily work of synthesis, purification, and characterization depends on people who know how mistakes emerge — not just from a lab notebook, but from lived experience. Evening shift operators remember past lessons and build on them. Chemists compare runs, spot trends, and suggest adjustments well before routine metrics catch a problem. Customer conversations — not only sales calls, but technical deep-dives and process sharing — build the knowledge base that keeps each batch consistent and safe. For us, manufacturing syrosingopine remains both a technical challenge and a human one. Every milestone, every lesson learned, tracks back to those collaborative moments where production meets partnership and expertise turns into real results.